Diagnostic antibodies and antigens for pain-related acetaminophen (Paracetamol) toxicity testing

Acetaminophen is known as paracetamol in many countries outside the US. It is one of the most frequently used oral analgesics and antipyretics. It has an outstanding safety profile when administered in an appropriate dose, but hepatotoxicity can occur after overdose or when misused in at-risk populations. GENEMEDI developed the antigens and antibodies for the diagnosis of potential acetaminophen toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Classification: Paracetamol

acetaminophen (Paracetamol)

Cat No.	Species	Biomarker	Disease	Cat No.of Antigen	Bioactivity validation of Antigen	Cat No.of Antibodies	Bioactivity validation of Antibodies	Order
GMP-SMT-Paracetamol	Human	acetaminophen (Paracetamol)	hepatotoxicity	GMP-SMT-Paracetamol-Ag01: BSA-acetaminophen (Paracetamol); GMP-SMT-Paracetamol-Ag02: OVA-acetaminophen (Paracetamol)	Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-acetaminophen (Paracetamol)], acetaminophen (Paracetamol) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation.	GMP-SMT-Paracetamol-Ab01: Anti-acetaminophen (Paracetamol) mouse monoclonal antibody(mAb)	Human acetaminophen (Paracetamol) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in Paracetamol level test of Pain (hepatotoxicity) and related syndrome evaluation.